首页> 外文会议>Congress of the International Society for Mushroom Science >Research and Development of a Ganoderma lucidum Polysaccharide Injection Formulation
【24h】

Research and Development of a Ganoderma lucidum Polysaccharide Injection Formulation

机译:Ganoderma lucidum多糖注射配方的研究与开发

获取原文

摘要

The aim of this study was to investigate the effect of injecting polysaccharides from Ganoderma lucidum into hosts for clinical practice. The polysaccharide aqueous extracts of Ganoderma lucidum' s fruit body was purified by Deproteinization of Sevage method, anion-exchange chromatography elution, dialysis, ethanol precipitation, active carbon filter, and millipore membrane filter technique. The injection was prepared from purified Ganoderma lucidum polysaccharide (GLPS). Polysaccharide indexes, protein, tannin, heavy metal, arsenic salt, oxalate, potassium ion, resin, pH, ignition residue, evaluation criterion of allergic reaction, total solids content of the GLPS injection were all tested with the reference method in Chinese Pharmacopoeia (2010ed). The results showed that the key component of injection was polysaccharide, ignition residue and total solids content were 1.4% and 2. 4%, respectively, the other indices were all within expected safety ranges. Notably, the injection improved the antifatigue capacity of mice with no effect in weight.
机译:本研究的目的是探讨将多糖从Ganoderma Lucidum注入多糖中的临床实践中的疗效。通过可脱蛋白,通过可脱蛋白,阴离子交换色谱洗脱,透析,乙醇沉淀,活性炭过滤器和Millipore膜过滤技术纯化Ganoderma lucidum果体的多糖水性提取物。注射由纯化的Ganoderma荧光蛋白多糖(GLP)制备。多糖指数,蛋白质,单宁,重金属,砷盐,草酸盐,钾离子,树脂,pH,点火残渣,过敏反应评价标准,Glps注射的总固体含量全部用中国药典中的参考方法进行测试(2010年)。结果表明,注射剂的关键组分是多糖,点火残留物和总固体含量为1.4%和2. 4%,其他指数都在预期的安全范围内。值得注意的是,注射改善了小鼠的抗衰叠能力,其重量没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号